Login Register Cart 0
Generic placeholder image

Current HIV Research

Editor-in-Chief

ISSN (Print): 1570-162X
ISSN (Online): 1873-4251

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Research Article

Prevalence and Causes of Vitamin D Deficiency in a Cohort of Greek HIV-Infected Individuals: A Prospective, Single Center, Observational Study

In Press, (this is not the final "Version of Record"). Available online 13 June, 2024
Author(s): Theodoros Androutsakos*, Marianna Politou, Sofia Boti, Theodoros Pittaras, Athanasios Kontos, Theodore Kordossis, Abraham Pouliakis and George Panayiotakopoulos
Published on: 13 June, 2024

DOI: 10.2174/011570162X302844240605104855

Price: $95

Abstract

Background: Vitamin D deficiency and/or insufficiency (hypovitaminosis D) has been associated with several disorders including autoimmune diseases, like type 1 diabetes mellitus; cardiovascular diseases; neoplasms; obesity; insulin resistance, and type 2 diabetes mellitus. This problem is common in southern European countries, especially in elderly and institutionalized persons. In HIV-infected individuals, hypovitaminosis D has been correlated with various complications like tuberculosis, hyperparathyroidism, bone mass loss, premature atherosclerosis, and systemic arterial hypertension, deterioration of immune function, progression of the disease and overall mortality.

Objective: The objective of this study was to examine the prevalence and causes of hypovitaminosis D in a cohort of Greek HIV-infected patients, the factors, and possible complications associated with it.

Methods: All patients attending our HIV unit for a period of 5 months were included in this study. Vitamin D status, medical anamnes, and laboratory tests were obtained at baseline; patients were followed for 3 years and HIV-related complications were noted. No patient received vitamin D supplementation during the follow-up period.

Results: Hypovitaminosis D was common, with 83.7% of the patients showing levels below 30ng/dl and 55.4% below 20ng/dl. After multivariable analysis, age and duration of treatment were the only significant factors for low vitamin D levels. During follow-up, 26 patients exhibited a total of 34 HIV-related complications, the most common being pneumonocystis jiroveci pneumonia (PCP). Hypovitaminosis D showed a positive correlation with overall complications, PCP as well as wasting syndrome.

Conclusion: Overall, our study shows that hypovitaminosis D is common in HIV-infected individuals and should probably be treated as soon as possible to protect these patients from serious HIVrelated complications like PCP or wasting syndrome.

[1]
Adams JS, Hewison M. Update in vitamin D. J Clin Endocrinol Metab 2010; 95(2): 471-8.
[http://dx.doi.org/10.1210/jc.2009-1773] [PMID: 20133466]
[2]
Bikle D. Nonclassic actions of vitamin D. J Clin Endocrinol Metab 2009; 94(1): 26-34.
[http://dx.doi.org/10.1210/jc.2008-1454] [PMID: 18854395]
[3]
Oyedele T, Adeyemi OM. High prevalence of vitamin D deficiency in HIV-infected adults: What are the future research questions? Curr HIV/AIDS Rep 2012; 9(1): 1-4.
[http://dx.doi.org/10.1007/s11904-011-0101-9] [PMID: 22187389]
[4]
Saraiva GL, Cendoroglo MS, Ramos LR. Prevalência da deficiência, insuficiência de vitamina D e hiperparatireoidismo secundário em idosos institucionalizados e moradores na comunidade da cidade de São Paulo, Brasil. Arq Bras Endocrinol Metab 2010; 51(3): 12.
[5]
Canuto JMP, Canuto VMP, Lima MHA, et al. Risk factors associated with hypovitaminosis D in HIV/aids-infected adults. Arch Endocrinol Metab 2015; 59(1): 34-41.
[http://dx.doi.org/10.1590/2359-3997000000007] [PMID: 25926112]
[6]
Amrein K, Scherkl M, Hoffmann M, et al. Vitamin D deficiency 2.0: An update on the current status worldwide. Eur J Clin Nutr 2020; 74(11): 1498-513.
[http://dx.doi.org/10.1038/s41430-020-0558-y] [PMID: 31959942]
[7]
Choi AI, Lo JC, Mulligan K, et al. Association of vitamin D insufficiency with carotid intima-media thickness in HIV-infected persons. Clin Infect Dis 2011; 52(7): 941-4.
[http://dx.doi.org/10.1093/cid/ciq239] [PMID: 21273298]
[8]
Greene-Finestone LS, Berger C, de Groh M, et al. 25-Hydroxyvitamin D in Canadian adults: Biological, environmental, and behavioral correlates. Osteoporos Int 2011; 22(5): 1389-99.
[http://dx.doi.org/10.1007/s00198-010-1362-7] [PMID: 20730415]
[9]
Lai YC, Chen YH, Liang FW, et al. Determinants of cancer incidence and mortality among people with vitamin D deficiency: An epidemiology study using a real-world population database. Front Nutr 2023; 10: 1294066.
[http://dx.doi.org/10.3389/fnut.2023.1294066] [PMID: 38130443]
[10]
Hendriks S, Ranson JM, Peetoom K. Risk factors for young-onset dementia in the UK Biobank. JAMA Neurol 2023; 81(2): 134-42.
[http://dx.doi.org/10.1001/jamaneurol.2023.4929] [PMID: 38147328]
[11]
Samanta I, Patil DJ, More CB. Assessment of vitamin D levels in patients with oral potentially malignant disorders and oral squamous cell carcinoma-A cross-sectional study. J Oral Biol Craniofac Res 2024; 14(1): 27-32.
[http://dx.doi.org/10.1016/j.jobcr.2023.11.005] [PMID: 38130424]
[12]
Camargo CA Jr, Schaumberg DA, Friedenberg G, et al. Effect of daily vitamin D supplementation on risk of upper respiratory infection in older adults: A randomized controlled trial. Clin Infect Dis. Clin Infect Dis 2024; 78(5): 1162-9.
[http://dx.doi.org/10.1093/cid/ciad770]
[13]
Jiang L, Zhi S, Wei C, Rong Z, Zhang H. Serum 25(OH)D levels are associated with disease activity and renal involvement in initial-onset childhood systemic lupus erythematosus. Front Pediatr 2023; 11: 1252594.
[http://dx.doi.org/10.3389/fped.2023.1252594] [PMID: 38111622]
[14]
Abukanna AMA, Alanazi RFA, Alruwaili FS, Alayyashi AZM, Alanzi F, Vitamin D. Vitamin D deficiency as a risk factor for diabetes and poor glycemic control in Saudi Arabia: A systematic review. Cureus 2023; 15(11): e48577.
[http://dx.doi.org/10.7759/cureus.48577] [PMID: 38073984]
[15]
Kim MS, Lee JS, Chung SJ, Soh Y. Association between vitamin D and short-term functional outcomes in acute ischemic stroke. Nutrients 2023; 15(23): 4957.
[http://dx.doi.org/10.3390/nu15234957] [PMID: 38068815]
[16]
Liu J, Tian C, Tang Y, Geng B. Associations of the serum vitamin D with mortality in postmenopausal women. Clin Nutr 2024; 43(1): 211-7.
[http://dx.doi.org/10.1016/j.clnu.2023.11.041] [PMID: 38086258]
[17]
Chen CW, Han YY, Hwang JS, et al. Association between adequate serum 25(OH)D levels and atherogenic dyslipidemia in young adults. J Atheroscler Thromb 2023; 31(5): 524-39.
[http://dx.doi.org/10.5551/jat.64523] [PMID: 38057082]
[18]
Aagaard K, Møllegaard Jepsen JR, Sevelsted A. High-dose vitamin D3 supplementation in pregnancy and risk of neurodevelopmental disorders in the children at age 10: A randomized clinical trial. Am J Clin Nutr 2024; 119(2): 362-70.
[http://dx.doi.org/10.1016/j.ajcnut.2023.12.002]
[19]
Massa A, Isasi-Fuster A, Requena C, Manrique-Silva E, Kumar R, Nagore E. Nodular type but not vitamin D Levels increases the risk of second primary cancers in melanoma patients: An observational study of 663 patients. Actas Dermosifiliogr 2024; 115(2): T143-9.
[http://dx.doi.org/10.1016/j.ad.2023.10.038]
[20]
Arnqvist HJ, Leanderson P, Spångeus A. Vitamin D status in longstanding type 1 diabetes and controls. Association with upper extremity impairments. Ups J Med Sci 2023; 128
[http://dx.doi.org/10.48101/ujms.v128.9888] [PMID: 38084202]
[21]
Boggess KA, Espinola JA, Moss K, Beck J, Offenbacher S, Camargo CA Jr. Vitamin D status and periodontal disease among pregnant women. J Periodontol 2011; 82(2): 195-200.
[http://dx.doi.org/10.1902/jop.2010.100384] [PMID: 20809861]
[22]
Haugen M, Brantsæter AL, Trogstad L, et al. Vitamin D supplementation and reduced risk of preeclampsia in nulliparous women. Epidemiology 2009; 20(5): 720-6.
[http://dx.doi.org/10.1097/EDE.0b013e3181a70f08] [PMID: 19451820]
[23]
Maghbooli Z, Hossein-nezhad A, Karimi F, Shafaei AR, Larijani B. Correlation between vitamin D 3 deficiency and insulin resistance in pregnancy. Diabetes Metab Res Rev 2008; 24(1): 27-32.
[http://dx.doi.org/10.1002/dmrr.737] [PMID: 17607661]
[24]
Bodnar LM, Catov JM, Zmuda JM, et al. Maternal serum 25-hydroxyvitamin D concentrations are associated with small-for-gestational age births in white women. J Nutr 2010; 140(5): 999-1006.
[http://dx.doi.org/10.3945/jn.109.119636] [PMID: 20200114]
[25]
Viljakainen HT, Korhonen T, Hytinantti T, et al. Maternal vitamin D status affects bone growth in early childhood—a prospective cohort study. Osteoporos Int 2011; 22(3): 883-91.
[http://dx.doi.org/10.1007/s00198-010-1499-4] [PMID: 21153404]
[26]
Belderbos ME, Houben ML, Wilbrink B, et al. Cord blood vitamin D deficiency is associated with respiratory syncytial virus bronchiolitis. Pediatrics 2011; 127(6): e1513-20.
[http://dx.doi.org/10.1542/peds.2010-3054] [PMID: 21555499]
[27]
Díaz-López A, Paz-Graniel I, Alonso-Sanz R, Marqués Baldero C, Mateos Gil C, Arija Val V. Vitamin D deficiency in primary health care users at risk in Spain. Nutr Hosp 2021; 38(5): 1058-67.
[http://dx.doi.org/10.20960/nh.03565]
[28]
Díaz-Rizzolo DA, Kostov B, Gomis R, Sisó-Almirall A. Paradoxical suboptimal vitamin D levels in a Mediterranean area: A population-based study. Sci Rep 2022; 12(1): 19645.
[http://dx.doi.org/10.1038/s41598-022-23416-1] [PMID: 36385623]
[29]
Souberbielle JC, Massart C, Brailly-Tabard S, Cavalier E, Chanson P. Prevalence and determinants of vitamin D deficiency in healthy French adults: The VARIETE study. Endocrine 2016; 53(2): 543-50.
[http://dx.doi.org/10.1007/s12020-016-0960-3] [PMID: 27106800]
[30]
Galeazzi T, Quattrini S, Pjetraj D, et al. Vitamin D status in healthy Italian school-age children: A single-center cross-sectional study. Ital J Pediatr 2023; 49(1): 27.
[http://dx.doi.org/10.1186/s13052-023-01422-x] [PMID: 36814347]
[31]
Morsilli O, Guerriero R, Palmieri L, et al. Vitamin D status in a rural italian population. Reports 2021; 5(1): 1.
[http://dx.doi.org/10.3390/reports5010001]
[32]
Capuano R, Marchese F, Sica R, et al. Epidemiologic data of vitamin D deficiency and its implication in cardio-cerebrovascular risk in a Southern Italian Population. J Nutr Metab 2021; 2021: 1-8.
[http://dx.doi.org/10.1155/2021/5550222] [PMID: 34211785]
[33]
Challa A, Ntourntoufi A, Cholevas V, Bitsori M, Galanakis E, Andronikou S. Breastfeeding and vitamin D status in Greece during the first 6 months of life. Eur J Pediatr 2005; 164(12): 724-9.
[http://dx.doi.org/10.1007/s00431-005-1757-1] [PMID: 16143866]
[34]
Lapatsanis D, Moulas A, Cholevas V, et al. Vitamin D: A necessity for children and adolescents in Greece. Calcif Tissue Int 2005; 77(6): 348-55.
[http://dx.doi.org/10.1007/s00223-004-0096-y] [PMID: 16362463]
[35]
Xyda SE, Kotsa K, Doumas A, Papanastasiou E, Garyfallos AA, Samoutis G. Could the majority of the greek and cypriot population be Vitamin D deficient? Nutrients 2022; 14(18): 3778.
[http://dx.doi.org/10.3390/nu14183778] [PMID: 36145154]
[36]
Bouloukaki I, Markakis M, Pateli R, Lyronis I, Schiza S, Tsiligianni I. Vitamin D levels in primary care patients: Correlations with clinical, seasonal, and quality-of-life parameters. Fam Pract 2022; 39(4): 678-84.
[http://dx.doi.org/10.1093/fampra/cmac012] [PMID: 35325110]
[37]
Mehta S, Mugusi FM, Spiegelman D, et al. Vitamin D status and its association with morbidity including wasting and opportunistic illnesses in HIV-infected women in Tanzania. AIDS Patient Care STDS 2011; 25(10): 579-85.
[http://dx.doi.org/10.1089/apc.2011.0182] [PMID: 21916603]
[38]
Szep Z, Guaraldi G, Shah SS, et al. Vitamin D deficiency is associated with type 2 diabetes mellitus in HIV infection. AIDS 2011; 25(4): 525-9.
[http://dx.doi.org/10.1097/QAD.0b013e328342fdfd] [PMID: 21178753]
[39]
Hileman CO, Overton ET, McComsey GA. Vitamin D and bone loss in HIV. Curr Opin HIV AIDS 2016; 11(3): 277-84.
[http://dx.doi.org/10.1097/COH.0000000000000272] [PMID: 26890209]
[40]
Nguyen HS, Van Tran K, Chen SY, Tam KW. A systematic review and meta-analysis of randomized controlled trials of the effects of vitamin D supplementation on children and young adults with HIV infection. J Nutr 2023; 153(1): 138-47.
[http://dx.doi.org/10.1016/j.tjnut.2022.10.008] [PMID: 36913447]
[41]
Viard JP, Souberbielle JC, Kirk O. Vitamin D and clinical disease progression in HIV infection: Results from the EuroSIDA study. AIDS 2011; 25(10): 1305-5.
[42]
Jiménez-Sousa MÁ, Martínez I, Medrano LM, Fernández-Rodríguez A, Resino S. Vitamin D in human immunodeficiency virus infection: Influence on immunity and disease. Front Immunol 2018; 9: 458.
[http://dx.doi.org/10.3389/fimmu.2018.00458] [PMID: 29593721]
[43]
Shepherd L, Souberbielle JC, Bastard JP, et al. Prognostic value of vitamin D level for all-cause mortality, and association with inflammatory markers, in HIV-infected persons. J Infect Dis 2014; 210(2): 234-43.
[http://dx.doi.org/10.1093/infdis/jiu074] [PMID: 24493824]
[44]
Verma P, Shrivastava A, Siddiqui SA, et al. Effect of vitamin D supplementation on CD4 count in HIV-infected children and adolescents in North India: A non-randomized comparative study. J Trop Pediatr 2022; 68(5): fmac066.
[http://dx.doi.org/10.1093/tropej/fmac066] [PMID: 35944184]
[45]
Lee S, Lee JE, Lee SO, Sim YK, Lee SH. Influence of vitamin D deficiency on the development of opportunistic infection in people living with HIV/AIDS (PWHAs). J Am Coll Nutr 2021; 40(6): 545-50.
[http://dx.doi.org/10.1080/07315724.2020.1805043] [PMID: 32790581]
[46]
Calza L, Borderi M, Granozzi B, et al. Vitamin D insufficiency is associated with subclinical atherosclerosis in HIV-1-infected patients on combination antiretroviral therapy. HIV Res Clin Pract 2019; 20(6): 131-9.
[http://dx.doi.org/10.1080/25787489.2020.1724749] [PMID: 32065065]
[47]
Cheru LT, Saylor CF, Fitch KV, et al. Low vitamin D is associated with coronary atherosclerosis in women with HIV. Antivir Ther 2019; 24(7): 505-12.
[http://dx.doi.org/10.3851/IMP3336] [PMID: 31742564]
[48]
Welz T, Childs K, Ibrahim F, et al. Efavirenz is associated with severe vitamin D deficiency and increased alkaline phosphatase. AIDS 2010; 24(12): 1923-8.
[http://dx.doi.org/10.1097/QAD.0b013e32833c3281] [PMID: 20588161]
[49]
Nylén H, Habtewold A, Makonnen E, et al. Prevalence and risk factors for efavirenz-based antiretroviral treatment–associated severe vitamin D deficiency. Medicine (Baltimore) 2016; 95(34): e4631.
[http://dx.doi.org/10.1097/MD.0000000000004631] [PMID: 27559961]
[50]
Havers FP, Detrick B, Cardoso SW, et al. Change in vitamin d levels occurs early after antiretroviral therapy initiation and depends on treatment regimen in resource-limited settings. PLoS One 2014; 9(4): e95164.
[http://dx.doi.org/10.1371/journal.pone.0095164] [PMID: 24752177]
[51]
Legeai C, Vigouroux C, Souberbielle JC, et al. Associations between 25-hydroxyvitamin D and immunologic, metabolic, inflammatory markers in treatment-naive HIV-infected persons: The ANRS CO9 «COPANA» cohort study. PLoS One 2013; 8(9): e74868.
[http://dx.doi.org/10.1371/journal.pone.0074868] [PMID: 24058636]
[52]
Dao CN, Patel P, Overton ET, et al. Low vitamin D among HIV-infected adults: Prevalence of and risk factors for low vitamin D Levels in a cohort of HIV-infected adults and comparison to prevalence among adults in the US general population. Clin Infect Dis 2011; 52(3): 396-405.
[http://dx.doi.org/10.1093/cid/ciq158] [PMID: 21217186]
[53]
Visuthranukul J, Phansuea P, Buranakityanon P, Lerdrungroj P, Yamasmith E. Prevalence and risk factors of vitamin D deficiency among living with HIV adults receiving antiretroviral treatment in tropical area: Cross-sectional study. Heliyon 2023; 9(9): e19537.
[http://dx.doi.org/10.1016/j.heliyon.2023.e19537] [PMID: 37809448]
[54]
Wang Y, Huang X, Wu Y, et al. Increased risk of vitamin D deficiency among HIV-infected individuals: A systematic review and meta-analysis. Front Nutr 2021; 8: 722032.
[http://dx.doi.org/10.3389/fnut.2021.722032] [PMID: 34490331]
[55]
Kanwal W, Rehman A. High prevalence of vitamin D deficiency in HIV-infected individuals in comparison with the general population across Punjab province, Pakistan. Saudi J Biol Sci 2023; 30(1): 103484.
[http://dx.doi.org/10.1016/j.sjbs.2022.103484] [PMID: 36387030]
[56]
Havens PL, Tamhane A, Stephensen CB, et al. Short communication: Association of vitamin D Insufficiency and protective tenofovir diphosphate concentrations with bone toxicity in adolescent boys and young men using tenofovir disoproxil fumarate/emtricitabine for HIV pre-exposure prophylaxis. AIDS Res Hum Retroviruses 2019; 35(2): 123-8.
[http://dx.doi.org/10.1089/aid.2018.0096] [PMID: 30280906]
[57]
Calza L, di Pietro G, Colangeli V, et al. Factors associated with vitamin D deficiency in HIV-1 infected patients on combination antiretroviral therapy: A case-control study. New Microbiol 2019; 42(3): 145-9.
[PMID: 31305932]
[58]
Mikuła T, Sapuła M, Suchacz MM, et al. Risk factors of hypovitaminosis D in HIV-infected patients on suppressive antiretroviral therapy. AIDS Res Hum Retroviruses 2020; 36(8): 676-80.
[http://dx.doi.org/10.1089/aid.2019.0020] [PMID: 32408752]
[59]
Arpadi SM, Shiau S, Strehlau R, et al. Efavirenz is associated with higher bone mass in South African children with HIV. AIDS 2016; 30(16): 2459-67.
[http://dx.doi.org/10.1097/QAD.0000000000001204] [PMID: 27427876]
[60]
Schneider E, Whitmore S, Glynn KM, Dominguez K, Mitsch A, McKenna MT. Revised surveillance case definitions for HIV infection among adults, adolescents, and children aged <18 months and for HIV infection and AIDS among children aged 18 months to <13 years-United States, 2008. MMWR Recomm Rep 2008; 57(RR-10): 1-12.
[PMID: 19052530]
[61]
Theodorou M, Sersté T, Van Gossum M, Dewit S. Factors associated with vitamin D deficiency in a population of 2044 HIV-infected patients. Clin Nutr 2014; 33(2): 274-9.
[http://dx.doi.org/10.1016/j.clnu.2013.04.018] [PMID: 23680190]
[62]
Cervero M, Agud JL, García-Lacalle C, et al. Prevalence of vitamin D deficiency and its related risk factor in a Spanish cohort of adult HIV-infected patients: Effects of antiretroviral therapy. AIDS Res Hum Retroviruses 2012; 28(9): 963-71.
[http://dx.doi.org/10.1089/aid.2011.0244] [PMID: 22242918]
[63]
Crutchley RD, Gathe J Jr, Mayberry C, Trieu A, Abughosh S, Garey KW. Risk factors for vitamin D deficiency in HIV-infected patients in the south central United States. AIDS Res Hum Retroviruses 2012; 28(5): 454-9.
[64]
Aziz M, Livak B, Burke-Miller J, et al. Vitamin D insufficiency may impair CD4 recovery among Women's Interagency HIV Study participants with advanced disease on HAART. AIDS 2013; 27(4): 573-8.
[http://dx.doi.org/10.1371/journal.pone.0222878] [PMID: 31550271]
[65]
Ezeamama AE, Guwatudde D, Wang M, et al. Vitamin-D deficiency impairs CD4+T-cell count recovery rate in HIV-positive adults on highly active antiretroviral therapy: A longitudinal study. Clin Nutr 2016; 35(5): 1110-7.
[http://dx.doi.org/10.1016/j.clnu.2015.08.007] [PMID: 26371397]
[66]
Kim JH, Gandhi V, Psevdos G Jr, Espinoza F, Park J, Sharp V. Evaluation of vitamin D levels among HIV-infected patients in New York City. AIDS Res Hum Retroviruses 2012; 28(3): 235-41.
[http://dx.doi.org/10.1089/aid.2011.0040] [PMID: 21644847]
[67]
Nugmanova Z, Patel N, Akhmetova GM, et al. Relationship between vitamin D and human immunodeficiency virus (HIV) viral load among HIV-infected patients in Kazakhstan. J Infect Dev Ctries 2015; 9(11): 1277-83.
[http://dx.doi.org/10.3855/jidc.6808] [PMID: 26623638]
[68]
Flauzino T, Simao ANC, de Almeida ERD, et al. Association between vitamin D status, oxidative stress biomarkers and viral load in Human Immunodeficiency Virus Type 1 infection. Curr HIV Res 2017; 15(5): 336-44.
[PMID: 28990534]
[69]
Lozano-Ros A, Martínez-Ginés ML, García-Domínguez JM, et al. Changes in the expression of TGF-beta regulatory pathway genes induced by vitamin D in patients with relapsing-remitting multiple sclerosis. Int J Mol Sci 2023; 24(19): 14447.
[http://dx.doi.org/10.3390/ijms241914447] [PMID: 37833895]
[70]
Gunville C, Mourani P, Ginde A. The role of vitamin D in prevention and treatment of infection. Inflamm Allergy Drug Targets 2013; 12(4): 239-45.
[http://dx.doi.org/10.2174/18715281113129990046] [PMID: 23782205]
[71]
Adams JS, Hewison M. Unexpected actions of vitamin D: New perspectives on the regulation of innate and adaptive immunity. Nat Clin Pract Endocrinol Metab 2008; 4(2): 80-90.
[http://dx.doi.org/10.1038/ncpendmet0716] [PMID: 18212810]
[72]
Edfeldt K, Liu PT, Chun R, et al. T-cell cytokines differentially control human monocyte antimicrobial responses by regulating vitamin D metabolism. Proc Natl Acad Sci USA 2010; 107(52): 22593-8.
[http://dx.doi.org/10.1073/pnas.1011624108] [PMID: 21149724]
[73]
Sudfeld CR, Giovannucci EL, Isanaka S, et al. Vitamin D status and incidence of pulmonary tuberculosis, opportunistic infections, and wasting among HIV-infected Tanzanian adults initiating antiretroviral therapy. J Infect Dis 2013; 207(3): 378-85.
[http://dx.doi.org/10.1093/infdis/jis693] [PMID: 23162137]
[74]
Manion M, Hullsiek KH, Wilson EMP, et al. Vitamin D deficiency is associated with IL-6 levels and monocyte activation in HIV-infected persons. PLoS One 2017; 12(5): e0175517.
[http://dx.doi.org/10.1371/journal.pone.0175517] [PMID: 28464004]

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy